According to the summary report of Béres Gyógyszergyár Zrt., in 2021 the company achieved net sales of HUF 20.3 billion, after sales of HUF 20.1 billion a year earlier, writes the business daily Vilaggazdasag.
Revenues were split between HUF 15.3 billion from domestic sales and HUF 5 billion from export sales.
Last year, it generated an after-tax profit of HUF 3.67 billion, compared to HUF 4.7 billion in 2020.
The pharmaceutical company employed 561 people in 2021, up from 480 a year earlier.
According to the resolution of the general meeting, the company decided to pay a dividend of 700 million HUF.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing decent journalism is an expensive business. For 27 years, the editors, editors and reporters of Budapest Business Journal have strived to bring you business news that works, information you can trust, that is factual, accurate and presented without fear or favour.
News organizations around the world are struggling to find a business model that allows them to continue to excel, without compromising their ability to perform. More recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer this same opportunity to our readers. We would like to invite you to help us provide the quality business journalism you need. Hit our Support the BBJ button and you’ll be able to choose how much and how often you send us your contributions.